Morgan Stanley’s Allena Pharmaceuticals ALNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6
| Closed | – | – | 8138 |
|
|
2022
Q2 | $0 | Sell |
6
-11,539
| -100% | -$1.79K | ﹤0.01% | 8225 |
|
|
2022
Q1 | $3K | Sell |
11,545
-1,033,936
| -99% | -$428K | ﹤0.01% | 7715 |
|
|
2021
Q4 | $619K | Hold |
1,045,481
| – | – | ﹤0.01% | 5413 |
|
|
2021
Q3 | $943K | Hold |
1,045,481
| – | – | ﹤0.01% | 5085 |
|
|
2021
Q2 | $1.36M | Buy |
1,045,481
+407,599
| +64% | +$494K | ﹤0.01% | 4910 |
|
|
2021
Q1 | $887K | Sell |
637,882
-414,099
| -39% | -$690K | ﹤0.01% | 4805 |
|
|
2020
Q4 | $1.35M | Buy |
1,051,981
+354
| +0% | +$494 | ﹤0.01% | 4468 |
|
|
2020
Q3 | $1.56M | Sell |
1,051,627
-28,758
| -3% | -$40.4K | ﹤0.01% | 3883 |
|
|
2020
Q2 | $1.71M | Sell |
1,080,385
-173,462
| -14% | -$291K | ﹤0.01% | 3742 |
|
|
2020
Q1 | $1.21M | Buy |
1,253,847
+450,688
| +56% | +$902K | ﹤0.01% | 3807 |
|
|
2019
Q4 | $2.19M | Sell |
803,159
-894,429
| -53% | -$2.94M | ﹤0.01% | 3963 |
|
|
2019
Q3 | $6.69M | Sell |
1,697,588
-46,507
| -3% | -$200K | ﹤0.01% | 2556 |
|
|
2019
Q2 | $7.1M | Sell |
1,744,095
-41,377
| -2% | -$226K | ﹤0.01% | 2537 |
|
|
2019
Q1 | $12.5M | Sell |
1,785,472
-43,257
| -2% | -$314K | ﹤0.01% | 1812 |
|
|
2018
Q4 | $9.97M | Sell |
1,828,729
-27,911
| -2% | -$241K | ﹤0.01% | 2131 |
|
|
2018
Q3 | $19.9M | Buy |
1,856,640
+1,034,990
| +126% | +$11.4M | 0.01% | 1690 |
|
|
2018
Q2 | $10.7M | Buy |
821,650
+4,741
| +0.6% | +$68.4K | ﹤0.01% | 2312 |
|
|
2018
Q1 | $9M | Buy |
816,909
+442,924
| +118% | +$3.7M | ﹤0.01% | 2446 |
|
|
2017
Q4 | $3.76M | Buy |
+373,985
| New | +$4.61M | ﹤0.01% | 3404 |
|
Other funds holding ALNA
Morgan Stanley's ALNA Position: Q3 2022 in Review
Morgan Stanley sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 6 shares.
Morgan Stanley first reported a position in ALNA in Q4 2017 and held it in 19 quarters. The position peaked at $19.9M in Q3 2018. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.
- Morgan Stanley reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- Morgan Stanley sold 6 Allena Pharmaceuticals shares in Q3 2022.
- Morgan Stanley first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 19 quarters.
- Morgan Stanley's Allena Pharmaceuticals position peaked at $19.9M in Q3 2018.
- 2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.